Paige.ai
A digital pathology AI company, acquired by Tempus AI in 2025, that builds software to help pathologists detect and grade cancer on digitised slides. Its products include suites for prostate, breast, gastrointestinal and pan-cancer detection, pathology foundation models, and Paige Alba, an AI assistant for pathologists.
● Use Cases
- →Highlighting suspected cancer regions on prostate biopsy slides
- →Supporting pathologists reviewing breast and gastrointestinal tissue
- →Prioritising slides that need urgent review
- →Answering pathologists' questions about a case through an assistant
● Tags
● Listed In
About Paige.ai
What is Paige.ai?
A digital pathology AI company, acquired by Tempus AI in 2025, that builds software to help pathologists detect and grade cancer on digitised slides. Its products include suites for prostate, breast, gastrointestinal and pan-cancer detection, pathology foundation models, and Paige Alba, an AI assistant for pathologists. Paige.ai is an AI healthcare tool that supports clinical workflows, administrative tasks, patient communication, and medical data analysis — always operating within healthcare compliance frameworks.
Paige holds US FDA clearance for some products, but Australian labs must check the TGA's ARTG for each product, because diagnostic AI is regulated as software as a medical device. Pathology services also operate under NATA accreditation and NPAAC standards, so any AI tool needs validation within your quality system. Slide images and reports are health information under the Privacy Act 1988 and state health records laws, and may flow into records covered by the My Health Records Act. Ask about data hosting and local support.
How Australian Businesses Use Paige.ai
Australian healthcare providers use AI tools for appointment scheduling, clinical note transcription, patient triage, insurance verification, and literature review — freeing clinical staff to focus on direct patient care.
Key Features
- ✓AI suites for prostate, breast, gastrointestinal and pan-cancer detection
- ✓Pathology foundation models trained on large slide collections
- ✓Paige Alba assistant answers pathologists' questions about cases
- ✓Paige Predict estimates biomarker likelihood from standard H&E slides
- ✓Available through partner digital pathology platforms and image management systems
Best For
- →Pathology laboratories with established digital slide workflows
- →Cancer research groups using pathology foundation models
- →Hospital networks scaling histopathology capacity
Pros & Cons of Paige.ai
✓ Strengths
- +Built specifically for pathologists working with digitised slides
- +Covers several cancer types across tissue suites
- +Some products hold FDA clearance in the United States
- +Backed by a larger precision medicine company
⚠ Limitations
- –Requires a digital pathology workflow and slide scanners
- –Australian regulatory status needs checking per product
- –Integration and validation take significant lab effort
- –Ownership change may affect product roadmap
Pricing
Licensed to pathology laboratories, hospitals and research organisations under enterprise agreements, often alongside slide scanning and image management systems. There is no public price list. Contact the vendor through paige.ai.
Details checked against the vendor's website in October 2026. Pricing changes often, so confirm current plans at paige.ai.
Data Residency & Privacy in Australia
Paige, now part of Tempus AI, does not publish an Australian hosting option on its website. Slide images and pathology reports are health information, so laboratories should ask whether processing happens on-premises, in a partner platform or in the vendor's cloud, which regions are used, and whether de-identified images are used to improve models. Check state health records law requirements on offshore storage.
Need AI that keeps client data onshore? See private AI hosted in Australia.
Getting Started with Paige.ai in Australia
Paige.ai is available directly at paige.ai. Verify the tool's compliance with Australian Privacy Act, My Health Records Act, and relevant TGA requirements before implementation. Start with administrative workflows (scheduling, documentation) rather than clinical decision support until your team is confident in the system.
Outside help is most useful when the tool has to connect to existing systems, handle personal information, or be rolled out to a whole team. AI Lab Australia works with businesses across Sydney, Melbourne, Brisbane, Perth and Adelaide on that setup.
Alternatives to Paige.ai
If Paige.ai is not the right fit for your workflow, these tools serve a similar purpose and are worth evaluating:
Frequently Asked Questions About Paige.ai
Is Paige approved for use in Australia?
Some Paige products hold US FDA clearance, but Australian supply depends on inclusion in the Australian Register of Therapeutic Goods. Check the ARTG for each specific product and intended use, and validate performance on your own case mix within your NATA-accredited quality system before clinical use.
Who owns Paige now?
Tempus AI acquired Paige in 2025. Paige products continue under the Paige name at paige.ai, and Tempus has since launched new offerings such as Paige Predict. Existing customers should check whether support arrangements, contracts or roadmaps have changed since the acquisition.
Does Paige need digital slide scanners?
Yes. Paige analyses digitised whole slide images, so a laboratory needs scanners and an image management system first. Some Paige products are offered through partner platforms, which can simplify integration if your lab already uses one of them.
Ready to Implement Paige.ai?
AI Lab Australia helps Australian businesses choose, set up and connect tools like Paige.ai to the systems they already run, with privacy and data handling sorted before rollout.